The regulation of NASH involves a delicate balance between pro-inflammatory M1 KCs and anti-inflammatory M2 KCs, with the activation of NLRP3 as a classical inflammasome in KCs (102). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.